Alpha Tau Medical Ltd Market Cap ($614.75 Million)
Market Cap & Net Worth: Alpha Tau Medical Ltd (DRTS)
Alpha Tau Medical Ltd market cap. Alpha Tau Medical Ltd (NASDAQ:DRTS) has a market capitalization of $614.75 Million ($614.75 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #10844 globally and #2872 in its home market, demonstrating a 5.04% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alpha Tau Medical Ltd's stock price $13.54 by its total outstanding shares 85264146 (85.26 Million). Also see cash flow conversion of Alpha Tau Medical Ltd for how efficiently the company converts equity into cash flow.
Alpha Tau Medical Ltd Market Cap History (2021–2026)
Alpha Tau Medical Ltd market cap history from 2021 to 2026. Data shows growth from $837.29 Million to $1.15 Billion (5.31% CAGR). Check Alpha Tau Medical Ltd (DRTS) stock price for real-time trading data and today's change.
Index Memberships
Alpha Tau Medical Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.02% | #300 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #1121 of 3165 |
Weight: Alpha Tau Medical Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Alpha Tau Medical Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Alpha Tau Medical Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Alpha Tau Medical Ltd equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of DRTS by Market Capitalization
Companies near Alpha Tau Medical Ltd in the global market cap rankings as of November 4, 2026. Also see Alpha Tau Medical Ltd balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Alpha Tau Medical Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Alpha Tau Medical Ltd (2021–2026)
Market capitalization of Alpha Tau Medical Ltd from 2021 to today. Between 2021 and today, Alpha Tau Medical Ltd's market cap moved from $837.29 Million to $ 1.15 Billion, with a yearly change of 5.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.15 Billion | +173.54% |
| 2025 | $422.06 Million | +59.68% |
| 2024 | $264.32 Million | +2.99% |
| 2023 | $256.65 Million | -5.35% |
| 2022 | $271.14 Million | -67.62% |
| 2021 | $837.29 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Alpha Tau Medical Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $614.75 Million USD |
| MoneyControl | $614.75 Million USD |
| MarketWatch | $614.75 Million USD |
| marketcap.company | $614.75 Million USD |
| Reuters | $614.75 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Alpha Tau Medical Ltd
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending cl… Read more